Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel J. George, MD
Duke Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tulane University
New Orleans, Louisiana, United States
- Chesapeake Urology Associates
Baltimore, Maryland, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Duke Cancer Center Cary
Cary, North Carolina, United States
- Unc Lineberger Cancer Center
Chapel Hill, North Carolina, United States
- Johnston Hematology and Oncology of Clayton
Clayton, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Maria Parham Hospital
Henderson, North Carolina, United States
- Scotland Memorial Hospital
Laurinburg, North Carolina, United States
- Southeastern Regional
Lumberton, North Carolina, United States
- Johnston Memorial Hospital
Smithfield, North Carolina, United States
- Spartanburg Regional
Spartanburg, South Carolina, United States
- Virginia Oncology Associates
Hampton, Virginia, United States
- Virginia Oncology Associates
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Jul 2017
- Primary completion
- 9 Jul 2024
- Completion
- 9 Jul 2024
- Last update posted
- 12 Sept 2025
- Registered enrollment
- 93
- Registry id
- NCT03098836
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.